Your browser doesn't support javascript.
loading
Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population.
Sawada, Genta; Niida, Atsushi; Uchi, Ryutaro; Hirata, Hidenari; Shimamura, Teppei; Suzuki, Yutaka; Shiraishi, Yuichi; Chiba, Kenichi; Imoto, Seiya; Takahashi, Yusuke; Iwaya, Takeshi; Sudo, Tomoya; Hayashi, Tomoatsu; Takai, Hiroki; Kawasaki, Yoshihiro; Matsukawa, Takashi; Eguchi, Hidetoshi; Sugimachi, Keishi; Tanaka, Fumiaki; Suzuki, Hiromichi; Yamamoto, Ken; Ishii, Hideshi; Shimizu, Makiko; Yamazaki, Hiroshi; Yamazaki, Makoto; Tachimori, Yuji; Kajiyama, Yoshiaki; Natsugoe, Shoji; Fujita, Hiromasa; Mafune, Kenichi; Tanaka, Yoichi; Kelsell, David P; Scott, Claire A; Tsuji, Shoji; Yachida, Shinichi; Shibata, Tatsuhiro; Sugano, Sumio; Doki, Yuichiro; Akiyama, Tetsu; Aburatani, Hiroyuki; Ogawa, Seishi; Miyano, Satoru; Mori, Masaki; Mimori, Koshi.
Afiliación
  • Sawada G; Department of Surgery, Kyushu University Beppu Hospital, Beppu, Japan; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan.
  • Niida A; Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Uchi R; Department of Surgery, Kyushu University Beppu Hospital, Beppu, Japan.
  • Hirata H; Department of Surgery, Kyushu University Beppu Hospital, Beppu, Japan.
  • Shimamura T; Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Suzuki Y; Laboratory of Functional Genomics, Department of Medical Genome Sciences, Graduate School of Frontier Sciences, University of Tokyo, Kashiwa, Japan.
  • Shiraishi Y; Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Chiba K; Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Imoto S; Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Takahashi Y; Department of Surgery, Kyushu University Beppu Hospital, Beppu, Japan; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan.
  • Iwaya T; Department of Surgery, Iwate Medical University, Morioka, Japan.
  • Sudo T; Department of Surgery, Kyushu University Beppu Hospital, Beppu, Japan.
  • Hayashi T; Laboratory of Molecular and Genetic Information, Institute of Molecular and Cellular Biosciences, University of Tokyo, Tokyo, Japan.
  • Takai H; Laboratory of Molecular and Genetic Information, Institute of Molecular and Cellular Biosciences, University of Tokyo, Tokyo, Japan.
  • Kawasaki Y; Laboratory of Molecular and Genetic Information, Institute of Molecular and Cellular Biosciences, University of Tokyo, Tokyo, Japan.
  • Matsukawa T; Department of Neurology, University of Tokyo, Japan.
  • Eguchi H; Department of Surgery, Kyushu University Beppu Hospital, Beppu, Japan.
  • Sugimachi K; Department of Surgery, Kyushu University Beppu Hospital, Beppu, Japan.
  • Tanaka F; Department of Surgery, Kyushu University Beppu Hospital, Beppu, Japan.
  • Suzuki H; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Yamamoto K; Department of Medical Chemistry, Kurume University School of Medicine, Kurume, Japan.
  • Ishii H; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan.
  • Shimizu M; Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Tokyo, Japan.
  • Yamazaki H; Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Tokyo, Japan.
  • Yamazaki M; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan.
  • Tachimori Y; Esophageal Surgery Division, National Cancer Center Hospital, Tokyo, Japan.
  • Kajiyama Y; Department of Esophageal and Gastroenterological Surgery, Juntendo University School of Medicine, Tokyo, Japan.
  • Natsugoe S; Department of Surgical Oncology and Digestive Surgery, Kagoshima University School of Medicine, Kagoshima, Japan.
  • Fujita H; Department of Surgery, Kurume University School of Medicine, Kurume, Japan.
  • Mafune K; Department of Surgery, Mitsui Kinen Hospital, Tokyo, Japan.
  • Tanaka Y; Division of Gastroenterological Surgery, Saitama Cancer Center, Saitama, Japan.
  • Kelsell DP; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Scott CA; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Tsuji S; Department of Neurology, University of Tokyo, Japan.
  • Yachida S; Division of Refractory Cancer Research, National Cancer Center Research Institute, Tokyo, Japan.
  • Shibata T; Division of Cancer Genomics, Center for Medical Genomics, National Cancer Center Research Institute, Tokyo, Japan; Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Sugano S; Laboratory of Functional Genomics, Department of Medical Genome Sciences, Graduate School of Frontier Sciences, University of Tokyo, Kashiwa, Japan.
  • Doki Y; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan.
  • Akiyama T; Laboratory of Molecular and Genetic Information, Institute of Molecular and Cellular Biosciences, University of Tokyo, Tokyo, Japan.
  • Aburatani H; Genome Science Laboratory, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
  • Ogawa S; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Miyano S; Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Mori M; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan. Electronic address: mmori@gesurg.med.osaka-u.ac.jp.
  • Mimori K; Department of Surgery, Kyushu University Beppu Hospital, Beppu, Japan. Electronic address: kmimori@tsurumi.beppu.kyushu-u.ac.jp.
Gastroenterology ; 150(5): 1171-1182, 2016 05.
Article en En | MEDLINE | ID: mdl-26873401
ABSTRACT
BACKGROUND &

AIMS:

Esophageal squamous cell carcinoma (ESCC) is the predominant form of esophageal cancer in Japan. Smoking and drinking alcohol are environmental risk factors for ESCC, whereas single nucleotide polymorphisms in ADH1B and ALDH2, which increase harmful intermediates produced by drinking alcohol, are genetic risk factors. We conducted a large-scale genomic analysis of ESCCs from patients in Japan to determine the mutational landscape of this cancer.

METHODS:

We performed whole-exome sequence analysis of tumor and nontumor esophageal tissues collected from 144 patients with ESCC who underwent surgery at 5 hospitals in Japan. We also performed single-nucleotide polymorphism array-based copy number profile and germline genotype analyses of polymorphisms in ADH1B and ALDH2. Polymorphisms in CYP2A6, which increase harmful effects of smoking, were analyzed. Functions of TET2 mutants were evaluated in KYSE410 and HEK293FT cells.

RESULTS:

A high proportion of mutations in the 144 tumor samples were C to T substitution in CpG dinucleotides (called the CpG signature) and C to G/T substitutions with a flanking 5' thymine (called the APOBEC signature). Based on mutational signatures, patients were assigned to 3 groups, which associated with environmental (drinking and smoking) and genetic (polymorphisms in ALDH2 and CYP2A6) factors. Many tumors contained mutations in genes that regulate the cell cycle (TP53, CCND1, CDKN2A, FBXW7); epigenetic processes (MLL2, EP300, CREBBP, TET2); and the NOTCH (NOTCH1, NOTCH3), WNT (FAT1, YAP1, AJUBA) and receptor-tyrosine kinase-phosphoinositide 3-kinase signaling pathways (PIK3CA, EGFR, ERBB2). Mutations in EP300 and TET2 correlated with shorter survival times, and mutations in ZNF750 associated with an increased number of mutations of the APOBEC signature. Expression of mutant forms of TET2 did not increase cellular levels of 5-hydroxymethylcytosine in HEK293FT cells, whereas knockdown of TET2 increased the invasive activity of KYSE410 ESCC cells. Computational analyses associated the mutations in NFE2L2 we identified with transcriptional activation of its target genes.

CONCLUSIONS:

We associated environmental and genetic factors with base substitution patterns of somatic mutations and provide a registry of genes and pathways that are disrupted in ESCCs. These findings might be used to design specific treatments for patients with esophageal squamous cancers.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Biomarcadores de Tumor / Polimorfismo de Nucleótido Simple / Genómica / Mutación Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Gastroenterology Año: 2016 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Biomarcadores de Tumor / Polimorfismo de Nucleótido Simple / Genómica / Mutación Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Gastroenterology Año: 2016 Tipo del documento: Article País de afiliación: Japón